Page 46 - 83_01

Trichomonas vaginalis: The versatility of a tenacious parasite Chemother 1996; 40: 1121-5.
235. Adagu IS, Nolder D, Warhurst DC, Rossignol JF. In
Linnaeus (Asteraceae) essential oil. Mem Inst
Oswaldo Cruz 2015; 110: 693-9. vitro activity of nitazoxanide and related compounds
against isolates of Giardia intestinalis, Entamoeba
220. Youse HA, Kazemian A, Sereshti M, et al. Effect of histolytica and Trichomonas vaginalis. J Antimicrob
Echinophora platyloba, Stachys lavandulifolia, and Chemoth 2002; 49: 103-11.
Eucalyptus camaldulensis plants on Trichomonas 236. Wright JM, Dunn LA, Kazimierczuk Z, et al.
vaginalis growth in vitro. Adv Biomed Res 2012; 1: Susceptibility in vitro of clinically metronidazole-
1-3. resistant Trichomonas vaginalis to nitazoxanide,
toyocamycin, and 2-fluoro-2'-deoxyadenosine,
221. Hassani S, Asghari G, Yousefi H, Kazemian A, Parasitol Res 2010; 107: 847-53.
Rafieiean M, Darani HY. Effects of different extracts 237. Blaha C, Duchêne M, Aspöck H, Walochnik J. In
of Eucalyptus camaldulensis on Trichomonas vitro activity of hexadecylphosphocholine
vaginalis parasite in culture medium. Adv Biomed (miltefosine) against metronidazole-resistant and-
Res 2013; 2: 1-11. susceptible strains of Trichomonas vaginalis. J
Antimicrob Chem 2006; 57: 273-8.
222. Taran M, Rezaeian M, Izaddoost M. In vitro 238. Dorlo TP, Balasegaram M, Beijnen JH, de Vries PJ.
antitrichomonas activity of Allium hirtifloium (Persian Miltefosine: a review of its pharmacology and
Shallot) in comparison with metronidazole. Irian J therapeutic efficacy in the treatment of
Public Health 2006; 35: 92-4. leishmaniasis. J Antimicrob Chem 2012; 67: 2576-97.
239. Rocha DAS, de Andrade Rosa I, de Souza W,
224. Sánchez-Arreola E, Hernández-Molina LR, Sánchez- Benchimol M. Evaluation of the effect of miltefosine
Salas JL, Martínez-Espino G. Alkaloids from on Trichomonas vaginalis. Par Res 2014; 113: 1041-7.
Bocconia frutescens. and biological activity of their 240. Wilkinson D, Ramjee G, Tholandi M, Rutherford G.
extracts. Pharm Biol 2006; 44: 540-3. Nonoxynol-9 for preventing vaginal acquisition of
sexually transmitted infections by women from men.
225. Esquenazi D, Wigg MD, Miranda MM, et al. Cochrane Database Syst Rev 2002; 4: CD003939.
Antimicrobial and antiviral activities of polyphenolics
from Cocos nucifera Linn.(Palmae) husk fiber extract. 47
Res Microbiol 2002; 153: 647-52.

226. Barbosa E, Calzada F, Campos R. In vivo antigiardial
activity of three flavonoids isolated of some medicinal
plants used in Mexican traditional medicine for the
treatment of diarrhea. J Ethnopharmacol 2007; 109:
552-4.

227. Damke E, Tsuzuki JK, Chassot F, et al. Spermicidal
and anti-Trichomonas vaginalis activity of Brazilian
Sapindus saponaria. BMC Complement Altern Med
2013; 13: 196-204.

228. de Brum Vieira P, Giordani RB, Macedo AJ, Tasca T.
Natural and synthetic compound anti-Trichomonas
vaginalis: an update review. Parasitol Res 2015; 114:
1249-61.

229. Helms DJ, Mosure DJ, Secor WE, Workowski KA.
Management of Trichomonas vaginalis in women
with suspected metronidazole hypersensitivity. Am J
Obstet Gynecol 2008; 198: 370-2.

230. Nyirjesy P, Gilbert J, Mulcahy LJ. Resistant
trichomoniasis: successful treatment with combination
therapy. Sex Transm Dis 2011; 38: 962-3.

231. Schwebke JR, Lensing SY, Sobel J. Intravaginal
metronidazole/tinidazole for the treatment of vaginal
trichomoniasis. Sex Transm Dis 2013; 40: 710-4.

232. Secor WE. Trichomonas vaginalis: treatment
questions and challenges. Expert Rev Anti Infect Ther
2012; 10: 107-9.

233. Aggarwal A, Shier RM. Recalcitrant Trichomonas
vaginalis infections successfully treated with vaginal
acidification. J Obstet Gynaecol Can 2008; 30: 55-8.

234. Narcisi EM, Secor WE. In vitro effect of tinidazole
and furazolidone on metronidazole-resistant
Trichomonas vaginalis. Antimicrob Agents

@Real Academia Nacional de Farmacia. Spain